Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pall Thor Ingvarsson

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Delivery|February 8, 2011
Stabilization of liposomes during dryingPall Thor Ingvarsson, Mingshi Yang, Hanne Mørck Nielsen, et al.
Pharmaceutical Research|June 25, 2013
Engineering of an inhalable DDA/TDB liposomal adjuvant: a quality-by-design approach towards optimization of the spray drying processPall Thor Ingvarsson, Mingshi Yang, Helle Mulvad, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 15, 2014
The surface charge of liposomal adjuvants is decisive for their interactions with the Calu-3 and A549 airway epithelial cell culture modelsPall Thor Ingvarsson, Ida Svahn Rasmussen, Michelle Viaene, et al.
Vaccine|April 28, 2018
Immunological and physical evaluation of the multistage tuberculosis subunit vaccine candidate H56/CAF01 formulated as a spray-dried powderAneesh Thakur, Pall Thor Ingvarsson, Signe Tandrup Schmidt, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 11, 2015
Engineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: A quality-by-design approachFabrice Rose, Jeanette Erbo Wern, Pall Thor Ingvarsson, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 19, 2013
Designing CAF-adjuvanted dry powder vaccines: spray drying preserves the adjuvant activity of CAF01Pall Thor Ingvarsson, Signe Tandrup Schmidt, Dennis Christensen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Delivery|February 8, 2011
Stabilization of liposomes during dryingPall Thor Ingvarsson, Mingshi Yang, Hanne Mørck Nielsen, et al.
Pharmaceutical Research|June 25, 2013
Engineering of an inhalable DDA/TDB liposomal adjuvant: a quality-by-design approach towards optimization of the spray drying processPall Thor Ingvarsson, Mingshi Yang, Helle Mulvad, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 15, 2014
The surface charge of liposomal adjuvants is decisive for their interactions with the Calu-3 and A549 airway epithelial cell culture modelsPall Thor Ingvarsson, Ida Svahn Rasmussen, Michelle Viaene, et al.
Vaccine|April 28, 2018
Immunological and physical evaluation of the multistage tuberculosis subunit vaccine candidate H56/CAF01 formulated as a spray-dried powderAneesh Thakur, Pall Thor Ingvarsson, Signe Tandrup Schmidt, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 11, 2015
Engineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: A quality-by-design approachFabrice Rose, Jeanette Erbo Wern, Pall Thor Ingvarsson, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 19, 2013
Designing CAF-adjuvanted dry powder vaccines: spray drying preserves the adjuvant activity of CAF01Pall Thor Ingvarsson, Signe Tandrup Schmidt, Dennis Christensen, et al.
Pageof 1